Calumet, Inc. <CLMT.O>: TD Cowen raises target price to $40 from $34
CLMT•Related News

CoreWeave, Inc. <CRWV.O>: Barclays Raises Target Price to $105 From $90
CRWV•

LeonaBio targets Phase 3 ELAINE-3 enrollment completion in Q4 2026, topline data seen in H2 2027
LONA•

PolyPid Q2 FY26 net loss narrows 22% to $7.8 million
PYPD•

Capstone Therapeutics restates Q3 2025 weighted-average shares, lifts loss per share to USD 0.34
CAPS•

Sutro Biopharma Q2 revenue misses estimates, posts wider loss
STRO•